Sign Up to Receive Your Personalised Learning Resources
CONFERENCE HUB
Per Ljungman, EBMT23: Outcomes and mortality in cytomegalovirus seropositive allogeneic stem cell transplantation patients with COVID-19
Start Learning
Sign up to view Favourites, Keep Notes and Track CME Credits
Favourites
Managing the practicalities of CAR T-cell therapies in patients with R/R MCL: Current considerations and future strategies
View
Marina Kremyanskaya, EHA 2023: Findings of the REVIVE study of rusfertide in polycythaemia vera
View
Higher-risk MDS and AML: How new guidelines are changing diagnosis, classification and management
View
The evolving treatment landscape in relapsed/refractory multiple myeloma
View
Revumenib in relapsed/refractory KMT2Ar acute leukaemia – AUGMENT-101 phase 2 study: Ibrahim Aldoss, ASH 2023
View
John Mascarenhas, EHA 2023: Overview and limitations of current therapeutic options for myelofibrosis
View
Renoir phase 3 study – rituximab and lenalidomide versus rituximab for elderly patients with r/r follicular lymphoma: Umberto Vitolo, ASH 2023
View
Anna Sureda, EBMT23: Updates on the GoCART coalition
View
Phase 3 BASIS trial – efficacy and safety of marstacimab in severe haemophilia A or B without inhibitors: Davide Matino, ASH 2023
View
Optimizing outcomes of JAK inhibition in myelofibrosis: Practical considerations for the clinic
View